Whitehawk Therapeutics (WHWK) EBIT (2010 - 2026)
Whitehawk Therapeutics (WHWK) reported EBIT of -$23.5 million for Q1 2026, down 54.57% year-over-year from -$51.8 million in Q1 2025, and down 127.61% on a QoQ basis from $85.2 million in Q4 2025.
Whitehawk Therapeutics (WHWK) has 17 years of EBIT data on file, last reported at -$23.5 million in Q1 2026.
- Quarterly EBIT fell 54.57% year-over-year to -$23.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$12.6 million (up 80.01% YoY) and the FY2025 annual result came in at -$4.3 million, up 93.59% from the prior year.
- EBIT retreated to -$23.5 million in Q1 2026 per WHWK's latest filing, from $85.2 million in the prior quarter.
- Across five years, EBIT topped out at $85.2 million in Q4 2025 and bottomed at -$54.7 million in Q2 2025.
- The 5-year median for EBIT is -$17.7 million (2023), against an average of -$13.5 million.
- The widest annual swing landed in 2022, when EBIT tumbled 373.81%; it then surged 549.56% in 2025.
- Tracing WHWK's EBIT over 5 years: stood at -$15.5 million in 2022, then fell by 14.49% to -$17.7 million in 2023, then slipped by 6.97% to -$18.9 million in 2024, then surged by 549.56% to $85.2 million in 2025, then slumped by 127.61% to -$23.5 million in 2026.
- Per Business Quant, the three latest WHWK EBIT figures stand at -$23.5 million (Q1 2026), $85.2 million (Q4 2025), and -$19.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.97 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -19.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.76 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.14 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.82 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 642.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 268.64 Mn |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - | -23.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.52 Mn |
| Dec 31, 2025 | 85.19 Mn |
| Sep 30, 2025 | -19.55 Mn |
| Jun 30, 2025 | -54.75 Mn |
| Mar 31, 2025 | -15.22 Mn |
| Dec 31, 2024 | -18.95 Mn |
| Sep 30, 2024 | -13.41 Mn |
| Jun 30, 2024 | -15.58 Mn |
| Mar 31, 2024 | -19.51 Mn |
| Dec 31, 2023 | -17.71 Mn |
| Sep 30, 2023 | -17.85 Mn |
| Jun 30, 2023 | -19.55 Mn |
| Mar 31, 2023 | -16.83 Mn |
| Dec 31, 2022 | -15.47 Mn |
| Sep 30, 2022 | -15.04 Mn |
| Jun 30, 2022 | -18.36 Mn |
| Mar 31, 2022 | -13.81 Mn |
| Dec 31, 2021 | -15.95 Mn |
| Sep 30, 2021 | -87.31 Mn |
| Jun 30, 2021 | -3.88 Mn |
| Mar 31, 2021 | -4.09 Mn |
| Dec 31, 2020 | 8.40 Mn |
| Sep 30, 2020 | -2.66 Mn |
| Jun 30, 2020 | 9.26 Mn |
| Mar 31, 2020 | -4.11 Mn |
| Dec 31, 2019 | -4.66 Mn |
| Sep 30, 2019 | -4.97 Mn |
| Jun 30, 2019 | -5.98 Mn |
| Mar 31, 2019 | -8.84 Mn |
| Dec 31, 2018 | -8.87 Mn |
| Sep 30, 2018 | 11.20 Mn |
| Jun 30, 2018 | -6.04 Mn |
| Mar 31, 2018 | -7.48 Mn |
| Dec 31, 2017 | -6.29 Mn |
| Sep 30, 2017 | -4.76 Mn |
| Jun 30, 2017 | -5.58 Mn |
| Mar 31, 2017 | -4.76 Mn |
| Dec 31, 2016 | -3.31 Mn |
| Sep 30, 2016 | -4.75 Mn |
| Jun 30, 2016 | -4.38 Mn |
| Mar 31, 2016 | -4.21 Mn |
| Dec 31, 2015 | -9,613.00 |
| Sep 30, 2015 | -4,328.00 |
| Jun 30, 2015 | -5,103.00 |
| Mar 31, 2015 | -3,962.00 |
| Dec 31, 2014 | -9,762.00 |
| Sep 30, 2014 | -4,765.00 |
| Jun 30, 2014 | -5,307.00 |
| Mar 31, 2014 | -4,138.00 |
| Dec 31, 2013 | -8,087.00 |
| Sep 30, 2013 | -4,475.00 |
| Jun 30, 2013 | -5,456.00 |
| Mar 31, 2013 | -4,806.00 |
| Dec 31, 2012 | -8,376.00 |
| Sep 30, 2012 | -4,753.00 |
| Jun 30, 2012 | -5,031.00 |
| Mar 31, 2012 | -4,231.00 |
| Dec 31, 2011 | -8,026.00 |
| Sep 30, 2011 | -5,430.00 |
| Jun 30, 2011 | -5,862.00 |
| Mar 31, 2011 | -4,266.00 |
| Dec 31, 2010 | -7,214.00 |
| Sep 30, 2010 | -4,238.00 |